FDA OKs Warner Chilcott's Atelvia for postmenopausal osteoporosis

10/11/2010 | Reuters

The FDA has approved Atelvia, Warner Chilcott's treatment for osteoporosis in postmenopausal women. The delayed-release tablet belongs to the Actonel family of bone drugs that Warner Chilcott purchased last year from Procter & Gamble.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA
Diagnostic Technician
Marlborough, MA
Test Technician
Marlborough, MA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
Ridgefield, CT